Abstract:Tumour cells have exquisite flexibility in reprogramming their metabolism in order to support tumour initiation, progression, metastasis and resistance to therapies. These reprogrammed activities include a complete rewiring of the bioenergetic, biosynthetic and redox status to sustain the increased energetic demand of the cells. Over the last decades, the cancer metabolism field has seen an explosion of new biochemical technologies giving more tools than ever before to navigate this complexity. Within a cell or a tissue, the metabolites constitute the direct signature of the molecular phenotype and thus their profiling has concrete clinical applications in oncology. Metabolomics and fluxomics, are key technological approaches that mainly revolutionized the field enabling researchers to have both a qualitative and mechanistic model of the biochemical activities in cancer. Furthermore, the upgrade from bulk to single-cell analysis technologies provided unprecedented opportunity to investigate cancer biology at cellular resolution allowing an in depth quantitative analysis of complex and heterogenous diseases. More recently, the advent of functional genomic screening allowed the identification of molecular pathways, cellular processes, biomarkers and novel therapeutic targets that in concert with other technologies allow patient stratification and identification of new treatment regimens. This review is intended to be a guide for researchers to cancer metabolism, highlighting current and emerging technologies, emphasizing advantages, disadvantages and applications with the potential of leading the development of innovative anti-cancer therapies.

Q&A with Ilaria Elia

Q&A with Ping Gao

Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Q&A with Hao Gu

Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeutics

Cellular Interaction and Metabolic Adaptations

The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment

Targeting Cancer Metabolism as a New Strategy to Enhance Treatment Efficacy and Overcome Resistance

Metabolism, Diet and Disease 2014: Cancer and metabolism

You are the tumor queen, microbiome fiend, IL-17

Editorial: Tumor microenvironment and metabolic reprogramming in cancer

Interview with the Guest Editor – Ana-Maria Lennon-Duménil

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy

The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates

Cancer immunometabolism: advent, challenges, and perspective

The cancer metabolic reprogramming and immune response

Metabolic rewiring and communication in cancer immunity

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

Editorial for Special Issue "Brain Tumor Microenvironment"